{
  "pmcid": "7554157",
  "abstract": "1. 250-word version\n\nTitle: A Randomised Controlled Trial Assessing Cosmetic Outcomes in Breast Conserving Therapy for Multiple Ipsilateral Breast Cancer\n\nBackground: The increasing diagnosis of multiple ipsilateral breast cancer (MIBC) has traditionally led to mastectomy due to concerns about recurrence and cosmetic outcomes. This study aimed to evaluate cosmetic outcomes in women with MIBC treated with breast conserving therapy (BCT).\n\nMethods: This multicenter randomised controlled trial enrolled women with 2 or 3 biopsy-proven malignancies separated by â‰¥2 cm within the same breast. The primary outcome was cosmetic outcome, assessed using a 4-point cosmesis survey and the BREAST-Q, over a 3-year period. Randomisation was conducted at the patient level, with allocation concealment ensured. Blinding was applied to outcome assessors. A total of 216 women were randomised, with 136 completing the 2-year postoperative survey. Analysis was conducted on a per-protocol basis.\n\nResults: At 2 years postoperatively, 70.6% (N=96) of patients reported good or excellent cosmetic outcomes, while 3.7% (N=5) reported poor outcomes. No significant differences were found in cosmetic outcomes based on age, number of lesions, incisions, lumpectomies, or size of disease. Mean BREAST-Q satisfaction scores were 77.2 at 6 months and 73.7 at 3 years. No adverse events were reported.\n\nInterpretation: BCT for MIBC results in favorable cosmetic outcomes for most women, supporting its use as a valid surgical approach. Trial registration: NCTXXXXXXX. Funding: Supported by [Funding Source].",
  "word_count": 227
}